ClinVar Miner

Submissions for variant NC_000011.10:g.(?_108365082)_(108365508_?)del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000228621 SCV000283093 pathogenic Ataxia-telangiectasia syndrome 2016-03-03 criteria provided, single submitter clinical testing This variant is a gross deletion of the genomic region encompassing exons 62-63 of the ATM gene, and is predicted to eliminate the final 106 amino acids of the protein (p.Val2951_Val3056del). The 5' boundary is likely confined to the intronic region between exons 61 and 62. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated ATM protein. A deletion encompassing exons 62-63 and the 3' UTR of ATM is reported as pathogenic and causative for autosomal recessive ataxia-telangiectasia (PMID: 9443866). In addition, multiple missense changes in these last two exons (PMID: 9872980, 12552566, 19781682), and a heterozygous deletion encompassing exon 63 (PMID: 23807571), have been reported as pathogenic. For these reasons, this deletion has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.